Actively Recruiting
A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)
Led by Takeda · Updated on 2026-01-26
600
Participants Needed
1
Research Sites
960 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study is about learning and documenting how well participants and physicians understand how to use GATTEX and about potential risks by using a survey (called Knowledge Assessment Survey). This survey, which is conducted every two years, is part of the Gattex Risk Evaluation and Mitigation Strategy (REMS). REMS is a safety program required by the US health authority (FDA) for certain medicines that have serious risks. REMS intends to help reduce these risks while still allowing treatment. The goal is to make sure these medicines are used in the safest way possible. The main aim of this survey is to find out how well participants and physicians understand the checkups and tests (so called monitoring) participants should have while taking GATTEX, and the possible risks or of using GATTEX to treat Short Bowel Syndrome. The knowledge assessment survey will be done via internet, telephone, or paper and both physicians and participants will be able to choose the method that is preferred. No study medicines will be provided to participants in this study.
CONDITIONS
Official Title
A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants 18 years of age or older who have taken GATTEX in the 60 days before the survey
- Caregivers may participate on behalf of eligible participants unable to complete the survey
- Participants who previously completed a GATTEX Patient Knowledge Assessment Survey are eligible
- Health care providers (adult and pediatric) in the U.S. who can provide a 10-digit National Provider Identifier (NPI) and have prescribed GATTEX at least once
- Health care providers who previously completed a GATTEX Prescriber Knowledge Assessment Survey are eligible
You will not qualify if you...
- Individuals who do not agree to participate in the survey
- Individuals currently working for Takeda Pharmaceuticals U.S.A., Inc., NPS Pharmaceuticals, Inc., Shire, UBC, or the FDA, or whose immediate family members work for these organizations
- Individuals who report having a conflict of interest
- Health care providers who have opted out of receiving communications about the GATTEX Prescriber Knowledge Assessment Survey for the current wave
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Takeda Pharmaceuticals, U.S.A., Inc.
Cambridge, Massachusetts, United States, 02142
Actively Recruiting
Research Team
T
Takeda Contact
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here